Drugs / PR1-primed lymphocyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00866346 | Mar 2008 → Mar 2015 | chronic myeloid leukemia | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PR1-primed lymphocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00866346 ↗ |
| Modality | Cell therapy | “donor immune cells (T lymphocytes)” NCT00866346 ↗ |